Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0F7GX
|
|||
Former ID |
DCL001133
|
|||
Drug Name |
ACE-011
|
|||
Synonyms |
116496-76-5; 4-Acetamido-3-ethoxynitrobenzene; N-(2-ethoxy-4-nitrophenyl)acetamide; Acetamide,N-(2-ethoxy-4-nitrophenyl)-; 2'-ETHOXY-4'-NITROACETANILIDE; CDS1_004703; AC1MEGDI; ACMC-20c3rb; CBMicro_030367; 2-Ethoxy-4-nitroacetanilide; Oprea1_342150; DivK1c_005743; ACE011; SCHEMBL2204761; KS-00002AMW; CTK4A9819; DTXSID60387001; XZWVZJDHIDYKPB-UHFFFAOYSA-N; MolPort-000-279-575; ZX-AT005552; ZINC5061120; OR9529; AKOS001044796; PS-6223; VZ36467; MCULE-3006561606; AB07920; AS02565; KB-71958; CC-31292; AJ-53053; Acetamide, N-(2-ethoxy-4-nitrop
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Anemia [ICD-11: 3A00-3A9Z; ICD-9: 280-285] | Phase 1 | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C10H12N2O4
|
|||
Canonical SMILES |
CCOC1=C(C=CC(=C1)[N+](=O)[O-])NC(=O)C
|
|||
InChI |
1S/C10H12N2O4/c1-3-16-10-6-8(12(14)15)4-5-9(10)11-7(2)13/h4-6H,3H2,1-2H3,(H,11,13)
|
|||
InChIKey |
XZWVZJDHIDYKPB-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 116496-76-5
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
3414326, 4411668, 8097559, 10096904, 11176552, 11340918, 11516277, 12749745, 17463144, 40844045, 47560590, 74448749, 87772630, 92716014, 93999907, 105592002, 111474389, 123045274, 125362900, 130912270, 134357030, 135370574, 141536087, 152197260, 162079469, 162309450, 162778137, 163778906, 164120647, 168962536, 170507670, 179179229, 184538123, 187567304, 203096065, 206258163, 223562224, 223931637, 228334289, 245853248, 249519529, 252352891
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Transforming growth factor beta (TGFB) | Target Info | Inhibitor | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of Acceleron Pharma (2011). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.